Verona Pharma plc (NASDAQ:VRNA) Q2 2024 Earnings Call Transcript August 8, 2024
Verona Pharma plc beats earnings expectations. Reported EPS is $-0.13831, expectations were $-0.35.
Operator: Welcome to Verona Pharma’s Second Quarter 2024 Financial Results and Operating Highlights Conference Call. At this time, all participants are in a listen-only mode. Earlier this morning, Verona Pharma issued a press release announcing its financial results for the 3 months ended June 30, 2024. A copy...
